Journal article

Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma

J Cebon, E Jäger, MJ Shackleton, P Gibbs, ID Davis, W Hopkins, S Gibbs, Q Chen, J Karbach, H Jackson, DP MacGregor, S Sturrock, H Vaughan, E Maraskovsky, A Neumann, E Hoffman, ML Sherman, A Knuth

Cancer Immunity | Published : 2003